Successful Grant Applications for LifeScience Projects
GRANT DEADLINES
Below you will find a list with the most important funding programs including the deadlines for proposal submission.
If you need further information regarding the programs, please call us: +49 30 7720 5920 or contact us via email: info@consultech.de.
The last update was made on January 18th, 2022 (information is provided without guarantee - we try to implement updates as quickly as possible)
German programmes
| Programm | Einreichungsdatum |
|---|---|
| Bund: Steuerliche Forschungszulage | laufend |
| BMBF: Medizintechnische Lösungen in die Patientenversorgung überführen | laufend |
| BMBF: Forschungsvorhaben zur Verbesserung der Explorations- und Integrationsphasen der IKT-Forschung | laufend |
| BMBF: Werkstoffplattform Hybride Materialien (HyMat) | laufend |
| BMWi: Zentrales Innovationsprogramm Mittelstand (ZIM) -MOMENTAN AUSGESETZT- | laufend |
| BMWI: "Digital jetzt" - Investitionsförderung für KMU | laufend |
| BMBF: Stärkung Deutschlands im Europäischen Forschungs- und Bildungsraum (Deutschland - Ungarn) | 26.01.2022 |
| DAlzG: Vorhaben in der Versorgungsforschung zur Verbesserung der Situation für Menschen mit Demenz und ihren Angehörigen | 31.01.2022 |
| DAlzG: Forschungsprojekte zur Demenz, z.B. Diagnose, innovative Therapien | 31.01.2022 |
| BMBF: Förderung von Projekten für die grenzüberschreitende Vernetzung und Entwicklung von Projektvorschlägen für Horizont Europa | 31.01.2022 |
| BMBF: Förderung von interdisziplinären Projekten zur Entwicklung und Erprobung von neuen Ansätzen der Datenanalyse und des Datenteilens in der Krebsforschung | 01.02.2022 |
| BMWi: Ideenwettbewerb „Neue Produkte für die Bioökonomie“ im Rahmen der Nationalen Bioökonomiestrategie | 01.02.2022 |
| BMBF: RUBIN- Regionale unternehmerische Bündnisse für Innovationen | 01.02.2022 |
| BML: Forschungs- und Entwicklungsvorhaben zur Sicherung einer nachhaltigen Ernährung landwirtschaftlicher Nutztiere unter sich wandelnden klimatischen Bedingungen | 10.02.2022 |
| BMBF: GO-Bio initial | 15.02.2022 |
| VW-Stiftung: Innovative approaches to antiviral drug development | 17.02.2022 |
| BMBF: multidisziplinäre transnationale Forschungsprojekten zur Prävention in der Personalisierten Medizin im ERA Netz „ERA PerMed“ | 17.02.2022 |
| BMEL: Förderung von Forschungs- und Entwicklungsvorhaben zur Erschließung und zum Einsatz alternativer Proteinquellen für die menschliche Ernährung | 23.02.2022 |
| EUREKA: Cluster Xecs (Elektronik-Innovationen) | 25.02.2022 |
| BMBF: Förderung von Projekten zum Thema „Integration der Region Mittelost- und Südosteuropa in den Europäischen Forschungsraum“ (Bridge2ERA2021) | 28.02.2022 |
| BMWi: Verbesserte Produktionskapazitäten sowie Forschung und Entwicklung bei Speziallipiden und anderen Hilfsstoffen für mRNA-Impfstoffe und andere mRNA-Arzneimittel | Modul 1: 28.01.2022 Weitere Module 30.03.; 30.06.; laufend |
| BMWi: Nutzung und Bau von Demonstrationsanlagen für die industrielle Bioökonomie | 01.03.2022 |
| BMBF: Transnationale Forschungsprojekte innerhalb der Joint Programming Initiative „JPIAMR“ zur Durchbrechung von Resistenzen durch innovatives Design | 08.03.2022 |
| BMEL: Gesunde Kulturpflanzen und nachhaltige Verfahren des Pflanzenschutzes | 10.03.2022 |
| BMBF: Alternativmethoden zum Tierversuch | 15.03.2022 |
| BMBF: Computational Life Sciences – KI-Methoden für die Systemmedizin | 23.03.2022 |
| BMBF: Eurostars 3 | 24.03.2022 |
| BMWi: 29 th IraSME Call | 30.03.2022 |
| BMBF: Afrikanisch-deutsche Forschungsnetzwerke für Gesundheitsinnovationen in Subsahara-Afrika (RHISSA) | 31.03.2022 |
| BMBF: KMU-innovativ „Bioökonomie, Medizintechnik, Materialforschung, Photonik, Mensch-Technik-Interaktion, Elektronik und autonomes Fahren, IKT, Produktionsforschung, Ressourceneffizienz und Klimaschutz“ | 15.04.2022 |
| BMBF: Erforschung, Entwicklung und Nutzung von Methoden der Künstlichen Intelligenz in KMU | 15.04.2022 |
| BMBF: Richtlinie zur Förderung von Nachwuchsgruppen aus den Natur-, Informationstechnologie- und Ingenieurwissenschaften: „Kreativer Nachwuchs forscht für die Bioökonomie“ | 15.07.2022 |
| BMBF: START-interaktiv: Interaktive Technologien für Gesundheit und Lebensqualität | 15.07.2022 |
Horizon Europe
Health - Cluster 1
Legende:
CSA = Coordination and Support Actions (100% funding rate)
IA = Innovative Action (70% funding rate)
mHealth = mobile health
CSA = Coordination and Support Actions (100% funding rate)
IA = Innovative Action (70% funding rate)
mHealth = mobile health
PcoA = Programme Co-fund Action
PCP = Pre-Commercial Procurement
PPIS = Public procurement of innovative solutions
RIA = Research and Innovation Actions (100% funding rate)
PCP = Pre-Commercial Procurement
PPIS = Public procurement of innovative solutions
RIA = Research and Innovation Actions (100% funding rate)
| Call-ID | Deadline | Topic | Funding per project [in mio. €] |
Funding rate | Call budget [in mio €] |
Process [stages] |
|---|---|---|---|---|---|---|
| Destination 1: Staying healthy in a rapidly changing society (STAYHLTH) | ||||||
| HLTH-2022-STAYHLTH-01-01 | 1st stage: 1.2.2022 2nd stage: 6.9.2022 |
Boosting mental health in Europe in times of change | 7 | RIA | 50 | 2 |
| HLTH-2022-STAYHLTH-01-04 | 1st stage: 1.2.2022 2nd stage: 6.9.2022 |
Trustworthy artificial intelligence (AI) tools to predict the risk of chronic non-communicable diseases and/or their progression | 6 | RIA | 60 | 2 |
| HLTH-2022-STAYHLTH-01-05 | 1st stage: 1.2.2022 2nd stage: 6.9.2022 |
Prevention of obesity throughout the life course | 10 | RIA | 60 | 2 |
| HLTH-2022-STAYHLTH-02-01 | 21.4.2022 | Personalised blueprint of chronic inflammation in health-to-disease transition | 7 | RIA | 50 | 1 |
| Destination 2: Living and working in a health-promoting environment | ||||||
| Environment and Health – (ENVHLTH) | ||||||
| HLTH-2022-ENVHLTH-04-01 | 21.4.2022 | Methods for assessing health-related costs of environ-mental stressors | 4 | RIA | 20 | 1 |
| Destination 3. Tackling diseases and reducing disease burden | ||||||
| Tackling diseases – (DISEASE) | ||||||
| HLTH-2022-DISEASE-06-02 | 1st stage: 1.2.2022 2nd stage: 6.9.2022 |
Preclinical development of the next generation of immune- therapies for diseases or disorders with unmet medical needs | 6 | RIA | 60 | 2 |
| HLTH-2022-DISEASE-06-03 | 1st stage: 1.2.2022 2nd stage: 6.9.2022 |
Vaccines 2.0 - developing the next generation of vaccines | 8 | RIA | 40 | 2 |
| HLTH-2022-DISEASE-06-04 | 1st stage: 1.2.2022 2nd stage: 6.9.2022 |
Development of new effective therapies for rare diseases | 8 | RIA | 60 | 2 |
| HLTH-2022-DISEASE-07-01 | 21.4.2022 | Support for the functioning of the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R) | 2 | CSA | 2 | 1 |
| HLTH-2022-DISEASE-07-02 | 21.4.2022 | Pandemic preparedness | 3 | RIA | 10 | |
| HLTH-2022-DISEASE-07-03 | 21.4.2022 | Non-communicable diseases risk reduction in adolescence and youth (Global Alliance for Chronic Diseases – GACD) | 3 | RIA | 25 | 1 |
| HLTH-2022-DISEASE-03-01 | 21.4.2022 | European partnership fostering an European Research Area (ERA) for health research | 30 | co-fund | 30 | 1 |
| Destination 4. Ensuring access to innovative, sustainable and high-quality health care | ||||||
| Ensuring access to innovative, sustainable and high-quality health care | ||||||
| HLTH-2022-CARE-08-02 | 21.4.2022 | Pre-commercial research and innovation procurement (PCP) for building the resilience of health care systems in the context of recovery | 5 | PCP | 25 | 1 |
| HLTH-2022-CARE-08-03 | 21.4.2022 | Public procurement of innovative solutions (PPI) for building the resilience of health care systems in the context of recovery | 5 | PPI | 15 | 1 |
| HLTH-2022-CARE-08-04 | 21.4.2022 | Better financing models for health systems | 5 | RIA | 30 | 1 |
| HLTH-2022-CARE-10-01 | 21.4.2022 | European partnership on transforming health and care systems | 100 | co-fund | 100 | 1 |
| Destination 5. Unlocking the full potential of new tools, technologies and digital solutions for a healthy society | ||||||
| Tools and technologies for a health society (TOOL) | ||||||
| HLTH-2022-TOOL-11-01 | 21.4.2022 | Optimising effectiveness in patients of existing prescription drugs for major diseases (except cancer) with the use of biomarkers | 10 | RIKA | 60 | 1 |
| HLTH-2022-TOOL-11-02 | 21.4.2022 | New methods for the effective use of real-world data and/or synthetic data in regulatory decision-making and/or in health technology assessment | 7 | RIA | 35 | 1 |
| HLTH-2022-TOOL-12-01 | 1st stage: 1.2.2022 2nd stage: 6.9.2022 |
Computational models for new patient stratification strategies | 6 | RIA | 60 | 2 |
| Destination 6. Maintaining an innovative, sustainable and globally competitive health industry | ||||||
| A competitive health-related industry | ||||||
| HLTH-2022-IND-13-01 | 21.4.2022 | Enhancing cybersecurity of connected medical devices | 6 | RIA | 20 | 1 |
| HLTH-2022-IND-13-02 | 21.4.2022 | Scaling up multi-party computation, data anonymization techniques, and synthetic data generation | 7 | RIA | 30 | 1 |
| HLTH-2022-IND-13-03 | 21.4.2022 | New pricing and payment models for cost-effective and affordable health innovations | 5 | RIA | 15 | 1 |
| HLTH-2022-IND-13-04 | 21.4.2022 | Setting up a European Smart Health Innovation Hub | 2 | CSA | 3 | 2 |
| HLTH-2022-IND-13-05 | 21.4.2022 | Setting up a European Electronic Health Record Exchange Format (EEHRxF) Ecosystem | 2 | CSA | 2 | 1 |
Digital, Industry and Space - Cluster 4
Legend:
CSA = Coordination and Support Actions (100% funding rate)
IA = Innovative Action (70% funding rate)
mHealth = mobile health
CSA = Coordination and Support Actions (100% funding rate)
IA = Innovative Action (70% funding rate)
mHealth = mobile health
PcoA = Programme Co-fund Action
PCP = Pre-Commercial Procurement
PPIS = Public procurement of innovative solutions
RIA = Research and Innovation Actions (100% funding rate)
PCP = Pre-Commercial Procurement
PPIS = Public procurement of innovative solutions
RIA = Research and Innovation Actions (100% funding rate)
| Call-ID | Deadline | Topic | Funding per project [in Mio €] |
Funding rate | Call-budget [in Mio €] |
Process [stages] |
|---|---|---|---|---|---|---|
| HORIZON EUROPE 2021-2022 – Digital, Industry and Space | ||||||
| Destination: Climate neutral, circular and digitised production | ||||||
| Green, flexible and advanced manufacturing | ||||||
| HORIZON-CL4-2022-TWIN-TRANSITION-01-01 | 30.3.2022 | Rapid reconfigurable production process chains (Made in Europe Partnership) | 8-10 | IA | 27,5 | 1 |
| HORIZON-CL4-2022-TWIN-TRANSITION-01-03 | 30.3.2022 | Excellence in distributed control and modular manufacturing (Made in Europe Partnership) | 4-6 | RIA | 21,5 | 1 |
| HORIZON-CL4-2022-TWIN-TRANSITION-01-04 | 30.3.2022 | Intelligent work piece handling in a full production line (Made in Europe Partnership) | 4-6 | RIA | 21,5 | 1 |
| Advanced digital technologies for manufacturing | ||||||
| HORIZON-CL4-2022-TWIN-TRANSITION-01-06 | 30.3.2022 | ICT Innovation for Manufacturing Sustainability in SMEs (I4MS2) (Made in Europe Partnership) | 4-8 | IA | 30 | 1 |
| HORIZON-CL4-2022-TWIN-TRANSITION-01-07 | 30.3.2022 | Digital tools to support the engineering of a Circular Economy (Made in Europe Partnership) | 3-6 | RIA | 22 | 1 |
| HORIZON-CL4-2022-TWIN-TRANSITION-01-11 | 30.3.2022 | Valorisation of CO/CO2 streams into added-value products of market interest (Processes4Planet Partnership) | 12-18 | IA | 42,5 | 1 |
| Destination: Increased autonomy in key strategic value chains for resilient industry | ||||||
| A digitised, resource-efficient and resilient industry 2021 | ||||||
| HORIZON-CL4-2022-RESILIENCE-01-10 | 30.3.2022 | Innovative materials for advanced (nano)electronic components and system | 3-5 | RIA | 20 | 1 |
| HORIZON-CL4-2022-RESILIENCE-01-13 | 30.3.2022 | Smart and multifunctional biomaterials for health innovations | 3-5 | RIA | 20 | 1 |
| Materials and data-cross-cutting actions | ||||||
| HORIZON-CL4-2022-RESILIENCE-01-19 | 30.3.2022 | Advanced materials modelling and characterisation | 4-6 | RIA | 18 | 1 |
| HORIZON-CL4-2022-RESILIENCE-01-25 | 30.3.2022 | Optimised Industrial Systems and Lines through digitalisation | 4-5 | IA | 15 | 1 |
| Improving the resilience and preparedness of EU businesses, especially SMEs and Startups | ||||||
| HORIZON-CL4-2022-RESILIENCE-01-21 | 30.3.2022 | Leveraging standardisation in Digital Technologies | 4,5 | CSA | 4,5 | 1 |
| HORIZON-CL4-2022-RESILIENCE-01-26 | 30.3.2022 | 'Innovate to transform' support for SME's sustainability transition | 5 | CSA | 10 | 1 |
| Destination: World leading data and computing technologies 2021 | ||||||
| Data sharing in the common European data spaces | ||||||
| HORIZON-CL4-2022-DATA-01-04 | 5.4.2022 | Technologies and solutions for data trading, monetizing, exchange and interoperability (AI, Data and Robotics Partnership) | 10-13 | IA | 52 | 1 |
| HORIZON-CL4-2022-DATA-01-01 | 5.4.2022 | Methods for exploiting data and knowledge for extremely precise outcomes (analysis, prediction, decision support), reducing complexity and presenting insights in understandable way | 8-12 | RIA | 33 | 1 |
| HORIZON-CL4-2022-DATA-01-05 | 5.4.2022 | Extreme data mining, aggregation and analytics technologies and solutions | 5 | RIA | 30 | 1 |
| From cloud to edge ot Internet of Things for European Data | ||||||
| HORIZON-CL4-2022-DATA-01-02 | 5.4.2022 | Cognitive Cloud: AI-enabled computing continuum from Cloud to Edge | 4-6 | RIA | 50 | 1 |
| HORIZON-CL4-2022-DATA-01-03 | 5.4.2022 | Programming tools for decentralised intelligence and swarms | 4-8 | RIA | 40 | 1 |
| Digital and emerging technologies for competetiveness and fit for the Green Deal | ||||||
| HORIZON-CL4-2022-DIGITAL-EMERGING-01-05 | 5.4.2022 | AI, Data and Robotics for Industry optimisation (including production and services) (AI, Data and Robotics Partnership) | 3-5 | IA | 19 | 1 |
| HORIZON-CL4-2022-DIGITAL-EMERGING-01-35 | 5.4.2022 | Advanced characterisation methodologies to assess and predict the health and environmental risks of nanomaterials | 2-3 | RIA | 17,5 | 1 |
| HORIZON-CL4-2022-DIGITAL-EMERGING-02-19 | 16.11.2022 | 2D materials-based devices and systems for biomedical applications | 6 | RIA | 6 | 1 |
Climate, Energy, Mobility - Cluster 5
Legend:
CSA = Coordination and Support Actions (100% funding rate)
IA = Innovative Action (70% funding rate)
mHealth = mobile health
CSA = Coordination and Support Actions (100% funding rate)
IA = Innovative Action (70% funding rate)
mHealth = mobile health
PcoA = Programme Co-fund Action
PCP = Pre-Commercial Procurement
PPIS = Public procurement of innovative solutions
RIA = Research and Innovation Actions (100% funding rate)
PCP = Pre-Commercial Procurement
PPIS = Public procurement of innovative solutions
RIA = Research and Innovation Actions (100% funding rate)
| Call-ID | Deadline | Topic | Funding per project [in mio. €] |
Funding rate | Call budget [in mio €] |
Process [stages] |
|---|---|---|---|---|---|---|
| HORIZON EUROPE 2021-2022 – Food, Bioeconomy, Natural Resources, Agriculture and Environment | ||||||
| Destination : Climate sciences and responses for the transformation towards climate neutrality | ||||||
| Sustainable, secure and competitive energy supply | ||||||
| HORIZON-CL5-2021-D3-03-09 | 23.02.2022 | Carbon-negative sustainable biofuel production | 5 | RIA | 15 | 1 |
| HORIZON-CL5-2021-D3-03-14 | 23.02.2022 | Demonstration of large-scale CHP technologies for a shift to the use of biogenic residues and wastes | 10 | IA | 10 | 1 |
| HORIZON-CL5-2022-D3-01-01 | 26.04.2022 | Demonstration of cost-effective advanced biofuel technologies utilizing existing industrial plants | 10 | IA | 20 | 1 |
| HORIZON-CL5-2022-D3-02-08 | 27.10.2022 | Demonstration of complete value chains for advanced biofuel and non-biological renewable fuel production | 10 | IA | 20 | 1 |
| HORIZON-CL5-2022-D3-03-02 | 10.01.2023 | Best international practice for scaling up sustainable biofuels | 3 | RIA | 9 | 1 |
| HORIZON-CL5-2022-D3-03-03 | 10.01.2023 | Efficient and circular artificial photosynthesis | 3-5 | RIA | 10 | 1 |
| HORIZON-CL5-2022-D3-03-06 | 10.01.2023 | Efficient and low-emission technologies for industrial use of combustion and gasification systems from low-value biogenic residues and wastes | 3-5 | RIA | 10 | 1 |
Food, bioeconomy, natural resources, agriculture and environment - Cluster 6
Legend:
CSA = Coordination and Support Actions (100% funding rate)
IA = Innovative Action (70% funding rate)
mHealth = mobile health
CSA = Coordination and Support Actions (100% funding rate)
IA = Innovative Action (70% funding rate)
mHealth = mobile health
PcoA = Programme Co-fund Action
PCP = Pre-Commercial Procurement
PPIS = Public procurement of innovative solutions
RIA = Research and Innovation Actions (100% funding rate)
PCP = Pre-Commercial Procurement
PPIS = Public procurement of innovative solutions
RIA = Research and Innovation Actions (100% funding rate)
Varia
| Call-ID | Deadline | Topic | Funding per project [in Mio €] |
Funding rate | Call-budget [in Mio €] |
Process [stages] |
|---|---|---|---|---|---|---|
| European Innovation Council (EIC) | ||||||
| tba | main proposal: 06.04.2022 15.06.2022 05.10.2022 (expected dates) |
EIC Accelerator 2022 "Open", "Technologies for Open Strategic Autonomy", "Technologies for ‘Fit for 55’" |
max 2,5 | EIC | tba | 3 |
Innovative Health Initiative (IHI JU)
The first calls are expected around May 2022. The following topics appear to be covered:
Single stage calls
Two stage calls
Single stage calls
- Innovative patient-facing care pathways for patients with neurodegenerative diseases and comorbidities
- Next generation imaging and image-guided diagnosis and therapy for cancer
- Precision oncology: Innovative patient-centric, multi-modal therapies against cancer
- Access and integration of heterogeneous health data for improved health care in diseases areas of high unmet public health need.
Two stage calls
- New tools for prediction, prevention and monitoring of cardio-metabolic diseases including secondary manifestations to enable timely intervention
- Strengthening EU clinical development excellence and innovation attractiveness: Harmonised methodology to promote the uptake of early feasibility studies (EFS)
EU4Health
| Call-ID | Deadline | Topic | Funding per project [in Mio €] |
Funding rate | Call-budget [in Mio €] |
Process [stages] |
|---|---|---|---|---|---|---|
| EU4H-2021-PJ-06 | 25.01.2022 | Action grants for developing a pilot project for an EU infrastructure ecosystem for the secondary use of health data for research, policy-making and regulatory purposes | 5 | 60-80% | 5 | 1 |
| EU4H-2021-PJ-07 | 25.01.2022 | Action grants to support implementation of best practices on the ground with direct impact on the effort to tackle mental health challenges during COVID-19 | 0,375-0,75 | 60-80% | 0,75 | 1 |
| EU4H-2021-PJ-08 | 25.01.2022 | Action grants to support actions to improve access to human papillomavirus vaccination | 1,2 | 60-80% | 1,2 | 1 |
| EU4H-2021-PJ-09 | 25.01.2022 | Action grants for the initiative ‘HealthyLifestyle4All’: promotion of healthy lifestyles | 1,4-4,4 | 60-80% | 4,4 | 1 |
| EU4H-2021-PJ-10 | 25.01.2022 | Action grants to reduce liver and gastric cancers caused by infections | 1-2 | 60-80% | 2 | 1 |
| EU4H-2021-PJ-11 | 25.01.2022 | Action grants for ‘EU Cancer Treatment Capacity and Capability Mapping’ project - Network of Comprehensive Cancer Centres | 1,2 | 60-80% | 1,2 | 1 |
| EU4H-2021-PJ-12 | 25.01.2022 | Action grants to create a ‘Cancer Survivor Smart Card’ | 1,8 | 60-80% | 1,8 | 1 |
| EU4H-2021-PJ-13 | 25.01.2022 | Action grants to support the implementation of best practices in community-based services for the human immunodeficiency virus (HIV) infection and acquired immunodeficiency syndrome (AIDS), tuberculosis, viral hepatitis and sexually transmitted infections | 1-5 | 60-80% | 5 | 1 |
| EU4H-2021-PJ-14 | 25.01.2022 | Action grants supporting training activities, implementation, and best practices | 1,4-7 | 60-80% | 7 | 1 |
| EU4H-2021-PJ-15 | 25.01.2022 | Action grants for ‘Cancer Diagnostic and Treatment for All’ including ‘Genomic for Public Health’ | 3-6 | 60-80% | 6 | 1 |
| EU4H-2021-PJ-16 | 25.01.2022 | Action grants for the Computer-aided Drug Repurposing for Cancer Therapy Project | 1,5-3 | 60-80% | 3 | 1 |
| EU4H-2021-PJ-17 | 25.01.2022 | Action grants to organise and collect data to understand the safety, quality and efficacy of therapies applied in the field of assisted reproduction and based on haematopoietic stem cells | 2 | 60-80% | 4 | 1 |
| EU4H-2021-PJ-18 | 25.01.2022 | Action grants boosting cancer preventiont hrough the use of the European Code against Cancer and other concerted actions | 1-1,5 | 60-80% | 2,5 | 1 |
| EU4H-2021-PJ-19 | 17.02.2022 | Action grants to support accreditation and certification of quality assurance schemes for breast, colorectal and cervical cancer screening programmes | 2 | 60-80% | 2 | 1 |
Mission cancer
| Call-ID | Deadline | Topic | Funding per project [in Mio €] |
Funding rate | Call-budget [in Mio €] |
Process [stages] |
|---|---|---|---|---|---|---|
| HORIZON-MISS-2021-CANCER-02-01 | 26.04.2022 | Develop new methods and technologies for cancer screening and early detection | 4-15 | RIA | 60 | 1 |
| HORIZON-MISS-2021-CANCER-02-02 | 26.04.2022 | Develop and validate a set of quality of life and patient preference measures for cancer patients and survivors | 11 | RIA | 11 | 1 |
| HORIZON-MISS-2021-CANCER-02-03 | 26.04.2022 | Better understanding of the impact of risk factors and health determinants on the development and progression of cancer | 4-15 | RIA | 54,65 | 1 |
Further international programmes
| Funding Organisation / Programme |
Title / Topic | Deadline |
|---|---|---|
| Coalition for Epidemic Preparedness Innovations (CEPI) | A platform trial approach to assess the immunogenicity and safety / reactogenicity of fractional COVID-19 vaccine(s) as an additional dose in primed populations (FraCT-CoV) | Call is open until funding allocation has been reached |
| European Joint Program on rare Diseases |
Development of new analytic tools and pathways to accelerate diagnosis and facilitate diagnostic monitoring of rare diseases | 16.02.2022 1st stage 15.06.2022 2nd stage |
| ERA-Net PerMed | Prevention in personalized medicine |
17.02.2022 1st stage 14.06.2022 2nd stage |
| Coalition for Epidemic Preparedness Innovations (CEPI) | Expanding the CEPI Centralized Laboratory Network for measurement of immune responses elicited by vaccine candidates against CEPI priority pathogens and other viruses | 18.02.2022 |
| European Medicines Agency (EMA) | Repurposing of authorised medicines: pilot to support not-for-profit organisations and academia | 28.02.2022 |
| Europäisches Innovations- und Technologieinstitut (EIT) | EIT Open Food Call | 28.02.2022 |
| Coalition for Epidemic Preparedness Innovations (CEPI) | RNA vaccine platform technologies and vaccine library development against emerging and select endemic infectious diseases:Focus area 1- advanced mRNA vaccine platform technologies | 28.02.2022 |
| EU Joint Programme – Neurodegenerative Disease Research (JPND) initiative | Understanding the mechanisms of non-pharmacological interventions on neurogenerative diseases |
01.03.2022 1st stage 28.06.2022 2nd stage |
| European Joint Program on rare Diseases – Networking Support Scheme (NSS) | Networking initiatives in the field of rare diseases and rare cancers | 01.03.2022 |
| Joint Programming Initiative on Antimicrobial Resistance (JPIAMR) | Disrupting drug resistance using innovative design | 08.03.2022 1st stage 05.07.2022 2nd stage |
| ERA-Net NEURON |
Cerebrovascular Diseases including Small Vessel and Brain Barrier Dysfunction | 08.03.2022 1st stage tba 2nd stage |
| Medicines for Malaria Venture | 20th Call for proposals: 1. Compounds having activity against Plasmodium falciparum blood stages and ideally an inability to select resistant mutants in vitro (TCP1) for use in treatment or chemoprevention (TCP1-TPP2) 2. Compounds addressing the key priorities of the malaria eradication agenda (TCP3 and TCP6) Compounds for Target Identification |
25.03.2022 |
| Coalition for Epidemic Preparedness Innovations (CEPI) | RNA vaccine platform technologies and vaccine library development against emerging and select endemic infectious diseases: Focus area 2 - novel RNA platform technologies | 31.12.2022 |